Rankings
▼
Calendar
CAI Q1 2014 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
CAI
Caris Life Sciences, Inc.
$5B
Q1 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$54M
Gross Profit
$36M
65.6% margin
Operating Income
$23M
42.0% margin
Net Income
$14M
26.3% margin
EPS (Diluted)
$0.63
QoQ Revenue Growth
-0.5%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
-$48M
Stock-Based Comp.
$409,000
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$1.3B
Stockholders' Equity
$429M
Cash & Equivalents
$40M
← FY 2014
All Quarters
Q2 2014 →